We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Patient Specific Talus Spacer Treats Avascular Necrosis

By HospiMedica International staff writers
Posted on 04 Mar 2021
An additively manufactured patient specific implant allows patients suffering from avascular necrosis (AVN) to regain motion and reduce pain in the ankle.

The Additive Orthopaedics (Little Silver, NJ, USA) Patient Specific Talus Spacer is a three dimension (3D) printed implant that is designed to provide a joint-sparing alternative to other surgical interventions commonly used in late-stage AVN that may disable motion of the ankle joint. More...
Constructed of a porous lattice structure in order to support bony in-growth, the advanced talus implant includes complex geometries that lead to enhanced osteointegration, which are not possible with traditional manufacturing processes.

The Patient Specific Talus Spacer is 3D printed for each patient individually, modeled from a computed tomography (CT) scan, and is fitted to the patient's specific anatomy. During the replacement surgery, the patient's talus bone is removed and replaced with the implant, which is made from cobalt chromium alloy. While fusion may become necessary in the future (should the condition worsen), the Additive Orthopaedics Talus Spacer provides a joint-sparing procedure, as it allows the patient to retain motion in the ankle joint.

“Avascular necrosis of the talus is extremely painful and debilitating for these patients. The Patient Specific Talus Spacer is another example of how 3D printed devices can improve the standard of care,” said Greg Kowalczyk, President of Additive Orthopaedics. “Surgical treatment options are below-the-knee amputation or joint fusion, which results in loss of motion of the ankle, and can have poor outcomes.”

AVN of the ankle joint is a serious and progressive condition that causes death of bone tissue stemming from a lack of blood supply to the area. It is often caused by a sudden injury--such as a broken bone or a dislocated joint--or sustained damage to the tissue that develops over time, causing the damaged bone to turn necrotic. When a joint is affected, such as the ankle, the cartilage also deteriorates, leading to arthritis and pain. Late-stage AVN of the ankle may result in the talus partially or fully collapsing.

Related Links:
Additive Orthopaedics


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Endoscopy Display
E190
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.